These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23796832)

  • 1. Synthesis of surfactant free PCL-PEG brushed nanoparticles with tunable degradation kinetics.
    Ferrari R; Colombo C; Casali C; Lupi M; Ubezio P; Falcetta F; D'Incalci M; Morbidelli M; Moscatelli D
    Int J Pharm; 2013 Sep; 453(2):551-9. PubMed ID: 23796832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicomponent polymeric nanoparticles enhancing intracellular drug release in cancer cells.
    Ahmed A; Liu S; Pan Y; Yuan S; He J; Hu Y
    ACS Appl Mater Interfaces; 2014 Dec; 6(23):21316-24. PubMed ID: 25333325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
    Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
    Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core-shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells.
    Surnar B; Sharma K; Jayakannan M
    Nanoscale; 2015 Nov; 7(42):17964-79. PubMed ID: 26465291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A methyl methacrylate-HEMA-CL(n) copolymerization investigation: from kinetics to bioapplications.
    Ferrari R; Rooney TR; Lupi M; Ubezio P; Hutchinson RA; Moscatelli D
    Macromol Biosci; 2013 Oct; 13(10):1347-57. PubMed ID: 23873662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin transport of PEGylated poly(ε-caprolactone) nanoparticles assisted by (2-hydroxypropyl)-β-cyclodextrin.
    Conte C; Costabile G; d'Angelo I; Pannico M; Musto P; Grassia G; Ialenti A; Tirino P; Miro A; Ungaro F; Quaglia F
    J Colloid Interface Sci; 2015 Sep; 454():112-20. PubMed ID: 26004575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural contributions of blocked or grafted poly(2-dimethylaminoethyl methacrylate) on PEGylated polycaprolactone nanoparticles in siRNA delivery.
    Lin D; Huang Y; Jiang Q; Zhang W; Yue X; Guo S; Xiao P; Du Q; Xing J; Deng L; Liang Z; Dong A
    Biomaterials; 2011 Nov; 32(33):8730-42. PubMed ID: 21885115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization, effect of architecture on crystallization of biodegradable poly(epsilon-caprolactone)-b-poly(ethylene oxide) copolymers with different arms and nanoparticles thereof.
    Hua C; Dong CM
    J Biomed Mater Res A; 2007 Sep; 82(3):689-700. PubMed ID: 17323321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
    Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
    Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
    Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatible thermoresponsive PEGMA nanoparticles crosslinked with cleavable disulfide-based crosslinker for dual drug release.
    Ulasan M; Yavuz E; Bagriacik EU; Cengeloglu Y; Yavuz MS
    J Biomed Mater Res A; 2015 Jan; 103(1):243-51. PubMed ID: 24616340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.
    Gu G; Xia H; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Chen H; Gao X; Chen J
    Biomaterials; 2013 Jan; 34(1):196-208. PubMed ID: 23069707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
    Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
    Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
    Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
    Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dodecanol-poly(D,L-lactic acid)-b-poly (ethylene glycol)-folate (Dol-PLA-PEG-FA) nanoparticles: evaluation of cell cytotoxicity and selecting capability in vitro.
    Wang S; Luo Y; Zeng S; Luo C; Yang L; Liang Z; Wang Y
    Colloids Surf B Biointerfaces; 2013 Feb; 102():130-5. PubMed ID: 23000678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entrapment and release kinetics of furosemide from pegylated nanocarriers.
    Youm I; Murowchick JB; Youan BB
    Colloids Surf B Biointerfaces; 2012 Jun; 94():133-42. PubMed ID: 22386795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
    Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of biodegradable PCL/PEG nanoparticles for neuroendocrine tumor targeted delivery of somatostatin analog.
    Dubey N; Varshney R; Shukla J; Ganeshpurkar A; Hazari PP; Bandopadhaya GP; Mishra AK; Trivedi P
    Drug Deliv; 2012 Apr; 19(3):132-42. PubMed ID: 22428685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.